高级检索
当前位置: 首页 > 详情页

Regulatory factors of Nrf2 in age-related macular degeneration pathogenesis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Five Year Program of Ophthalmology and Optometry 2019, Beijing Tong Ren Hospital, Capital Medical University, Beijing 100054, China. [2]Four Year Program of Traditional Chinese Pharmacy 2020, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China. [3]School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China. [4]Five Year Program of Ophthalmology and Optometry 2021, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China. [5]Beijing Key Laboratory of TCM Collateral Disease Theory Research, Beijing 100069, China. [6]Biochemistry & Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
出处:
ISSN:

摘要:
Age-related macular degeneration (AMD) is a complicated disease that causes irreversible visual impairment. Increasing evidences pointed retinal pigment epithelia (RPE) cells as the decisive cell involved in the progress of AMD, and the function of anti-oxidant capacity of PRE plays a fundamental physiological role. Nuclear factor erythroid 2 related factor 2 (Nrf2) is a significant transcription factor in the cellular anti-oxidant system as it regulates the expression of multiple anti-oxidative genes. Its functions of protecting RPE cells against oxidative stress (OS) and ensuing physiological changes, including inflammation, mitochondrial damage and autophagy dysregulation, have already been elucidated. Understanding the roles of upstream regulators of Nrf2 could provide further insight to the OS-mediated AMD pathogenesis. For the first time, this review summarized the reported upstream regulators of Nrf2 in AMD pathogenesis, including proteins and miRNAs, and their underlying molecular mechanisms, which may help to find potential targets via regulating the Nrf2 pathway in the future research and further discuss the existing Nrf2 regulators proved to be beneficial in preventing AMD.International Journal of Ophthalmology Press.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 眼科学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2022]版:
Q4 OPHTHALMOLOGY
最新[2023]版:
Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Five Year Program of Ophthalmology and Optometry 2019, Beijing Tong Ren Hospital, Capital Medical University, Beijing 100054, China.
通讯作者:
通讯机构: [6]Biochemistry & Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China. [*1]School of Basic Medical Sciences, Capital Medical University, No.10 Youanmen Wai Xitoutiao, Beijing 100069, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23402 今日访问量:0 总访问量:1276 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)